Cellares and City of Hope are partnering to evaluate automating CAR T manufacturing for glioblastoma brain cancer therapy.

In January 2024, the FDA updated its guidance on CAR-T therapies, emphasizing the need for enhanced safety and quality measures. This update followed a series of warnings regarding the risk of T cell ...

Peroxisomes are essential cell organelles that play a vital role in lipid metabolism and cellular detoxification. To perform these functions, numerous enzymes must be correctly transported into the ...

Strategic acquisition accelerates Title21’s mission to deliver integrated digital solutions for regulated healthcare and life ...

New research from Dana-Farber Cancer Institute shows that a new class of drug results in cell death in cancers, such as small cell lung cancer, with a disabled quality control cell cycle checkpoint ...

Cellares announced multiple strategic technology partners Sept. 17 to advance its Cell Q. NJBIZ has reported extensively on the cell therapy manufacturer, which operates a Smart Factory in Bridgewater ...